# Mark Toshner

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/mark-toshner/

## Facts

| Field | Value |
| --- | --- |
| Citations | 32,120 |
| Field | Pulmonary Hypertension Research and Treatments |
| h-index | 63 |
| i10-index | 147 |
| Last Known Institution | University of Cambridge |
| OpenAlex ID | https://openalex.org/A5040443453 |
| ORCID iD | https://orcid.org/0000-0002-3969-6143 |
| Works | 356 |

## Researcher papers

- [Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK](https://scholariq.org/papers/safety-and-efficacy-of-the-chadox1-ncov-19-vaccine-azd1222-against-sars-cov-2-an/)
- [2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension](https://scholariq.org/papers/2022-esc-ers-guidelines-for-the-diagnosis-and-treatment-of-pulmonary-2/)
- [2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension](https://scholariq.org/papers/2022-esc-ers-guidelines-for-the-diagnosis-and-treatment-of-pulmonary/)
- [Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials](https://scholariq.org/papers/single-dose-administration-and-the-influence-of-the-timing-of-the-booster-dose/)
- [SARS-CoV-2 evolution during treatment of chronic infection](https://scholariq.org/papers/sars-cov-2-evolution-during-treatment-of-chronic-infection/)
- [Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies](https://scholariq.org/papers/sensitivity-of-sars-cov-2-b-1-1-7-to-mrna-vaccine-elicited-antibodies/)
- [Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study](https://scholariq.org/papers/physical-cognitive-and-mental-health-impacts-of-covid-19-after-hospitalisation/)
- [Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study](https://scholariq.org/papers/clinical-characteristics-with-inflammation-profiling-of-long-covid-and/)
- [Long-term Use of Sildenafil in Inoperable Chronic Thromboembolic Pulmonary Hypertension](https://scholariq.org/papers/long-term-use-of-sildenafil-in-inoperable-chronic-thromboembolic-pulmonary/)
- [Phenotypic Characterization of <i>EIF2AK4</i> Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension](https://scholariq.org/papers/phenotypic-characterization-of-i-eif2ak4-i-mutation-carriers-in-a-large-cohort/)

## Researcher topics

- [Pulmonary Hypertension Research and Treatments](https://scholariq.org/topics/pulmonary-hypertension-research-and-treatments/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Long-Term Effects of COVID-19](https://scholariq.org/topics/long-term-effects-of-covid-19/)
- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)
- [Chronic Obstructive Pulmonary Disease (COPD) Research](https://scholariq.org/topics/chronic-obstructive-pulmonary-disease-copd-research/)

## Researcher university

- [University of Cambridge](https://scholariq.org/institutions/university-of-cambridge/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.